SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹4,082 Cr | ₹1,870 Cr | ₹2,846 Cr | ₹6,198 Cr | ₹931 Cr |
What is the latest Total Debt ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹4,082 Cr |
| Mar2025 | ₹1,870 Cr |
| Mar2024 | ₹2,846 Cr |
| Mar2023 | ₹6,198 Cr |
| Mar2022 | ₹931 Cr |
How is Total Debt of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,082 Cr | 118.31 | |
| Mar2025 | ₹1,870 Cr | -34.30 | |
| Mar2024 | ₹2,846 Cr | -54.09 | |
| Mar2023 | ₹6,198 Cr | 565.94 | |
| Mar2022 | ₹931 Cr | - | |
Compare Total Debt of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,400.7 Cr | 1.8% | 6.8% | 17.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹206,906.0 Cr | 6.7% | 18.5% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,521.0 Cr | -3.7% | 5.5% | 39.8% | Stock Analytics | |
| CIPLA | ₹119,032.0 Cr | 5.7% | 0.6% | -1.4% | Stock Analytics | |
| MANKIND PHARMA | ₹107,071.0 Cr | 1.4% | 1.8% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.1 Cr | -2% | -15.8% | -8.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 1.8% |
6.8% |
17.8% |
| SENSEX | 1.2% |
1.2% |
-5.5% |
You may also like the below Video Courses